Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC)

Stopped This study was never able to open due to lack of funding from the pharmaceutical company.

Conditions

• Prostate Cancer
• Castration-resistant Prostate Cancer

Interventions

• DRUG: Itraconazole
• DRUG: Orteronel

Sponsor

Emmanuel Antonarakis, MD

Collaborators

• [object Object]